Long-term development of excessive and inflexible nicotine taking by rats, effects of a novel treatment approach

Behavioural Brain Research

Volumn 217, Issue 2, 2011, Pages 261-270

  Galli, Gabriel ^a   Wolffgramm, Jochen ^a  

^a Medimod Research Institute GmbH   (Germany)

Author keywords

Addiction memory; Inflexible consumption; Nicotine; Therapy; Voluntary

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID; NICOTINE; PLACEBO; QUININE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DRUG SELF ADMINISTRATION; FLUID INTAKE; FOOD INTAKE; MALE; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKING CESSATION; SOCIAL BEHAVIOR; TOBACCO DEPENDENCE;

ADMINISTRATION, ORAL; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CHOICE BEHAVIOR; CONDITIONING, OPERANT; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DRINKING BEHAVIOR; EATING; MALE; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, WISTAR; TIME FACTORS; TOBACCO USE DISORDER;

EID: 78650419953     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.10.011     Document Type: Article

References (52)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders (DSM-IV-TR) 2000, American Psychiatric Association, Washington, DC. 4th ed.
2. Abrari K., Rashidy-Pour A., Semnanian S., Fathollahi Y. Post-training administration of corticosterone enhances consolidation of contextual fear memory and hippocampal long-term potentiation in rats. Neurobiol Learn Mem 2009, 91:260-265.
3. Batra A., Klingler K., Landfeldt B., Friederich H.M., Westin A., Danielsson T. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study. Clin Pharmacol Ther 2005, 78:689-696.
4. Belin D., Balado E., Piazza P.V., Deroche-Gamonet V. Pattern of intake and drug raving predict the development of cocaine addiction-like behavior in rats. Biol Psychiatry 2009, 65:863-868.
5. Biondolillo K., Pearce A.R., Louder M.C., McMickle A. Solution concentration influences voluntary consumption of nicotine under multiple bottle conditions. Pharmacol Biochem Behav 2009, 92:214-218.
6. Boening J.A. Neurobiology of an addiction memory. J Neural Transm 2001, 108:755-765.
7. Boening J.A. Addiction memory as a specific, individually learned memory imprint. Pharmacopsychiatry 2009, 42(Suppl. 1):S66-S68.
8. Boening J.A., Lesch O.M., Spanagel R., Wolffgramm J., Narita M., Sinclair D., et al. Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials. Alochol Clin Exp Res 2001, 25:127-131.
9. Caggiula A.R., Donny E.C., White A.R., Chaudhri N., Booth S., Gharib M.A., et al. Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 2001, 70:515-530.
10. Cohen A., Ettenberg A. Motivational effects of nicotine as measured in a runway model of drug self-administration. Behav Pharmacol 2007, 18:265-271.
11. Dadmarz M., Vogel W.H. Individual self-administration of nicotine by rats. Pharmacol Biochem Behav 2003, 76:425-432.
12. Deroche-Gamonet V., Belin D., Piazza P.V. Evidence for addiction-like behavior in the rat. Science 2004, 305:1014-1017.
13. Dias-Ferreira E., Sousa J.C., Melo I., Morgado P., Mesquita A.R., Cerqueira J.J., et al. Chorinc stress causes frontostriatal reorganization and affects decision-making. Science 2009, 325:621-625.
14. Fagerstrom K., Balfour D.J. Neuropharmacology and potential efficacy of new treatments for tobacco dependence. Expert Opin Investig Drugs 2006, 15:107-116.
15. Galli G., Wolffgramm J. Long-term voluntary d-amphetamine consumption and behavioral predictors for subsequent d-amphetamine addiction in rats. Drug Alcohol Depend 2004, 73:51-60.
16. Gourley S.L., Kedves A.T., Olausson P., Taylor J.R. A history of corticosterone exposure regulates fear extinction and cortical NR2B, GluR2/3, and BDNF. Neuropsychopharmacology 2009, 34:707-716.
17. Heyne A. The development of opiate addiction in the rat. Pharmacol Biochem Behav 1996, 53:11-25.
18. Heyne A., Wolffgramm J. The development of addiction to d-amphetamine in an animal model: same principles as for alcohol and opiate. Psychopharmacology (Berl) 1998, 140:510-518.
19. Heyne A., May T., Goll P., Wolffgramm J. Persisting consequences of drug intake: towards a memory of addiction. J Neural Transm 2000, 107:613-638.
20. Holmes A., Wellman C.L. Stress-induced prefrontal reorganization and executive dysfunction in rodents. Neurosci Biobehav Rev 2009, 33:773-783.
21. Hyman S.E. Addiction: a disease of learning and memory. Am J Psychiatry 2005, 162:1414-1422.
22. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006, 29:565-598.
23. Kameda G., Dadmarz M., Vogel W.H. Influence of various drugs on the voluntary intake of nicotine by rats. Neuropsychobiology 2000, 41:205-209.
24. Kenny P.J., Markou A. Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 2006, 31:1203-1211.
25. Khaksari M., Rashidy-Pour A., Vafaei A.A. Central mineralocorticoid receptors are indispensable for corticosterone-induced impairment of memory retrieval in rats. Neuroscience 2007, 149:729-738.
26. Le Foll B., Goldberg S.R. Effects of nicotine in experimental animals and humans: an update on addictive properties. Handb Exp Pharmacol 2009, 335-367.
27. Le Houezec J. Nicotine: abused substance and therapeutic agent. J Psychiatry Neurosci 1998, 23:95-108.
28. Maehler R., Dadmarz M., Vogel W.H. Determinants of the voluntary consumption of nicotine by rats. Neuropsychobiology 2000, 41:200-204.
29. Martin S., Henley J.M., Holman D., Zhou M., Wiegert O., van Spronsen M., et al. Corticosterone alters AMPAR mobility and facilitates bidirectional synaptic plasticity. PLoS One 2009, 4:e4714.
30. Miranda M.I., Quirarte G.L., Rodriguez-Garcia G., McGaugh J.L., Roozendaal B. Glucocorticoids enhance taste aversion memory via actions in the insular cortex and basolateral amygdala. Learn Mem 2008, 15:468-476.
31. Nagaraja N., Andrade C., Sudha S., Madan S.N., Chandra J.S., Venkataraman B.V. Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia. Psychopharmacology (Berl) 2007, 190:73-80.
32. Nestler E.J. Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem 2002, 78:637-647.
33. O'Dell L.E., Chen S.A., Smith R.T., Specio S.E., Balster R.L., Paterson N.E., et al. Extended access to nicotine self-administration leads to dependence: circadian measures, withdrawal measures, and extinction behavior in rats. J Pharmacol Exp Ther 2007, 320:180-193.
34. Paterson N.E., Markou A. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Psychopharmacology (Berl) 2004, 173:64-72.
35. Patkar A.A., Vergare M.J., Batra V., Weinstein S.P., Leone F.T. Tobacco smoking: current concepts in etiology and treatment. Psychiatry 2003, 66:183-199.
36. Raiff B.R., Dallery J. The generality of nicotine as a reinforcer enhancer in rats: effects on responding maintained by primary and conditioned reinforcers and resistance to extinction. Psychopharmacology (Berl) 2008, 201:305-314.
37. Robbins T.W., Ersche K.D., Everitt B.J. Drug addiction and the memory systems of the brain. Ann N Y Acad Sci 2008, 1141:1-21.
38. Roozendaal B. Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiol Learn Mem 2002, 78:578-595.
39. Roozendaal B. Systems mediating acute glucocorticoid effects on memory consolidation and retrieval. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:1213-1223.
40. Roozendaal B., Okuda S., de Quervain D.J., McGaugh J.L. Glucocorticoids interact with emotion-induced noradrenergic activation in influencing different memory functions. Neuroscience 2006, 138:901-910.
41. Slifer B.L. Schedule-induction of nicotine self-administration. Pharmacol Biochem Behav 1983, 19:1005-1009.
42. Smith A., Roberts D.C. Oral self-administration of sweetened nicotine solutions by rats. Psychopharmacology (Berl) 1995, 120:341-346.
43. Sorge R.E., Clarke P.B. Rats self-administer intravenous nicotine delivered in a novel smoking-relevant procedure: effects of dopamine antagonists. J Pharmacol Exp Ther 2009, 330:633-640.
44. Turyabahika-Thyen K., Wolffgramm J. Loss of flexibility in alcohol-taking rats: promoting factors. Eur Addict Res 2006, 12:210-221.
45. Vann R.E., Balster R.L., Beardsley P.M. Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats. Psychopharmacology (Berl) 2006, 184:482-493.
46. Wang X.Y., Zhao M., Ghitza U.E., Li Y.Q., Lu L. Stress impairs reconsolidation of drug memory via glucocorticoid receptors in the basolateral amygdala. J Neurosci 2008, 28:5602-5610.
47. Wolffgramm J. An ethopharmacological approach to the development of drug addiction. Neurosci Biobehav Rev 1991, 15:515-519.
48. Wolffgramm J., Heyne A. Social behavior, dominance, and social deprivation of rats determine drug choice. Pharmacol Biochem Behav 1991, 38:389-399.
49. Wolffgramm J., Heyne A. From controlled drug intake to loss of control: the irreversible development of drug addiction in the rat. Behav Brain Res 1995, 70:77-94.
50. Wolffgramm J., Galli G., Thimm F., Heyne A. Animal models of addiction: models for therapeutic strategies?. J Neural Transm 2000, 107:649-668.
51. World Health Organization International statistical classification of diseases and health problems (ICD-10) 1992, World Health Organization, Geneva. 10th ed.
52. Zhao L.Y., Zhang X.L., Shi J., Epstein D.H., Lu L. Psychosocial stress after reactivation of drug-related memory impairs later recall in abstinent heroin addicts. Psychopharmacology (Berl) 2009, 203:599-608.